Eisai Co., Ltd. Logo

Eisai Co., Ltd.

4523.T

(2.8)
Stock Price

4.957,00 JPY

3.01% ROA

3.78% ROE

49x PER

Market Cap.

1.596.502.368.568,00 JPY

20.36% DER

2.86% Yield

4.45% NPM

Eisai Co., Ltd. Stock Analysis

Eisai Co., Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Eisai Co., Ltd. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (12%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

3 ROE

ROE in an average range (6.1%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 ROA

The stock's ROA (5.06%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

5 PBV

The stock's PBV ratio (2.78x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

6 Revenue Growth

Over the past three years, this company's revenue has consistently grown, demonstrating a positive financial trend that makes it an appealing choice.

7 Net Profit Growth

Over the last three years, this company has consistently achieved net profit growth, indicating a favorable financial performance and making it an attractive investment option.

8 Assets Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

9 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (110.567) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

10 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

11 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

Eisai Co., Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Eisai Co., Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Eisai Co., Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Eisai Co., Ltd. Revenue
Year Revenue Growth
1999 302.470.000.000
2000 361.712.000.000 16.38%
2001 431.749.000.000 16.22%
2002 466.613.000.000 7.47%
2003 500.127.000.000 6.7%
2004 533.139.000.000 6.19%
2005 601.258.000.000 11.33%
2006 674.175.000.000 10.82%
2007 734.419.000.000 8.2%
2008 781.708.000.000 6.05%
2009 803.138.000.000 2.67%
2010 768.925.000.000 -4.45%
2011 647.925.000.000 -18.68%
2012 573.676.000.000 -12.94%
2013 600.353.000.000 4.44%
2014 548.465.000.000 -9.46%
2015 547.922.000.000 -0.1%
2016 539.097.000.000 -1.64%
2017 600.054.000.000 10.16%
2018 642.834.000.000 6.65%
2019 695.621.000.000 7.59%
2020 645.942.000.000 -7.69%
2021 756.226.000.000 14.58%
2022 744.402.000.000 -1.59%
2023 706.468.000.000 -5.37%
2023 741.751.000.000 4.76%
2024 756.116.000.000 1.9%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Eisai Co., Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
1999 46.703.000.000
2000 49.613.000.000 5.87%
2001 55.035.000.000 9.85%
2002 59.704.000.000 7.82%
2003 69.018.000.000 13.5%
2004 78.325.000.000 11.88%
2005 93.249.000.000 16%
2006 108.296.000.000 13.89%
2007 225.427.000.000 51.96%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 120.377.000.000 100%
2013 130.544.000.000 7.79%
2014 131.907.000.000 1.03%
2015 122.307.000.000 -7.85%
2016 112.478.000.000 -8.74%
2017 139.579.000.000 19.42%
2018 144.844.000.000 3.63%
2019 140.116.000.000 -3.37%
2020 150.299.000.000 6.78%
2021 171.738.000.000 12.48%
2022 172.999.000.000 0.73%
2023 166.512.000.000 -3.9%
2023 153.092.000.000 -8.77%
2024 166.944.000.000 8.3%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Eisai Co., Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
1999 127.050.000.000
2000 154.661.000.000 17.85%
2001 202.459.000.000 23.61%
2002 228.443.000.000 11.37%
2003 250.865.000.000 8.94%
2004 269.392.000.000 6.88%
2005 307.795.000.000 12.48%
2006 351.249.000.000 12.37%
2007 372.303.000.000 5.66%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 139.849.000.000 100%
2013 152.324.000.000 8.19%
2014 194.546.000.000 21.7%
2015 192.817.000.000 -0.9%
2016 179.677.000.000 -7.31%
2017 183.857.000.000 2.27%
2018 228.208.000.000 19.43%
2019 256.297.000.000 10.96%
2020 281.396.000.000 8.92%
2021 366.430.000.000 23.21%
2022 358.292.000.000 -2.27%
2023 371.144.000.000 3.46%
2023 374.421.000.000 0.88%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Eisai Co., Ltd. EBITDA
Year EBITDA Growth
1999 41.805.000.000
2000 56.777.000.000 26.37%
2001 91.744.000.000 38.11%
2002 84.223.000.000 -8.93%
2003 101.898.000.000 17.35%
2004 111.582.000.000 8.68%
2005 125.087.000.000 10.8%
2006 137.329.000.000 8.91%
2007 53.954.000.000 -154.53%
2008 148.845.000.000 63.75%
2009 144.720.000.000 -2.85%
2010 163.881.000.000 11.69%
2011 145.622.000.000 -12.54%
2012 125.318.000.000 -16.2%
2013 119.258.000.000 -5.08%
2014 69.707.000.000 -71.08%
2015 88.022.000.000 20.81%
2016 87.395.000.000 -0.72%
2017 105.951.000.000 17.51%
2018 117.853.000.000 10.1%
2019 163.225.000.000 27.8%
2020 90.210.000.000 -80.94%
2021 94.548.000.000 4.59%
2022 87.259.000.000 -8.35%
2023 71.000.000.000 -22.9%
2023 86.150.000.000 17.59%
2024 93.880.000.000 8.23%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Eisai Co., Ltd. Gross Profit
Year Gross Profit Growth
1999 210.789.000.000
2000 263.111.000.000 19.89%
2001 330.180.000.000 20.31%
2002 364.146.000.000 9.33%
2003 402.946.000.000 9.63%
2004 434.525.000.000 7.27%
2005 496.749.000.000 12.53%
2006 564.808.000.000 12.05%
2007 615.481.000.000 8.23%
2008 629.294.000.000 2.19%
2009 642.410.000.000 2.04%
2010 601.146.000.000 -6.86%
2011 474.572.000.000 -26.67%
2012 399.565.000.000 -18.77%
2013 412.195.000.000 3.06%
2014 354.870.000.000 -16.15%
2015 353.463.000.000 -0.4%
2016 343.192.000.000 -2.99%
2017 398.800.000.000 13.94%
2018 458.340.000.000 12.99%
2019 519.928.000.000 11.85%
2020 484.632.000.000 -7.28%
2021 581.395.000.000 16.64%
2022 566.565.000.000 -2.62%
2023 560.760.000.000 -1.04%
2023 563.774.000.000 0.53%
2024 597.088.000.000 5.58%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Eisai Co., Ltd. Net Profit
Year Net Profit Growth
1999 11.275.000.000
2000 23.322.000.000 51.66%
2001 36.799.000.000 36.62%
2002 41.027.000.000 10.31%
2003 50.148.000.000 18.19%
2004 55.505.000.000 9.65%
2005 63.410.000.000 12.47%
2006 70.614.000.000 10.2%
2007 -17.012.000.000 515.08%
2008 47.678.000.000 135.68%
2009 40.338.000.000 -18.2%
2010 67.394.000.000 40.15%
2011 58.511.000.000 -15.18%
2012 48.275.000.000 -21.2%
2013 32.955.000.000 -46.49%
2014 43.253.000.000 23.81%
2015 54.934.000.000 21.26%
2016 39.359.000.000 -39.57%
2017 51.845.000.000 24.08%
2018 63.386.000.000 18.21%
2019 121.767.000.000 47.94%
2020 41.942.000.000 -190.32%
2021 47.954.000.000 12.54%
2022 55.432.000.000 13.49%
2023 11.156.000.000 -396.88%
2023 42.407.000.000 73.69%
2024 42.324.000.000 -0.2%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Eisai Co., Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1999 152
2000 312 51.13%
2001 501 37.8%
2002 553 9.58%
2003 697 20.66%
2004 777 10.18%
2005 887 12.51%
2006 991 10.49%
2007 -59 1779.66%
2008 669 108.82%
2009 566 -18.2%
2010 946 40.17%
2011 821 -15.23%
2012 678 -21.27%
2013 537 -26.31%
2014 606 11.55%
2015 769 21.09%
2016 551 -39.64%
2017 725 24.03%
2018 221 -227.6%
2019 425 48%
2020 147 -191.1%
2021 167 12.57%
2022 193 13.47%
2023 79 -147.44%
2023 148 46.94%
2024 148 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Eisai Co., Ltd. Free Cashflow
Year Free Cashflow Growth
1999 10.872.000.000
2000 71.079.000.000 84.7%
2001 34.064.000.000 -108.66%
2002 34.064.000.000 0%
2003 47.591.000.000 28.42%
2004 9.995.000.000 -376.15%
2005 43.216.000.000 76.87%
2006 52.630.000.000 17.89%
2007 19.507.000.000 -169.8%
2008 59.237.000.000 67.07%
2009 76.688.000.000 22.76%
2010 100.097.000.000 23.39%
2011 71.137.000.000 -40.71%
2012 53.354.000.000 -33.33%
2013 63.584.000.000 16.09%
2014 57.597.000.000 -10.39%
2015 55.545.000.000 -3.69%
2016 55.850.000.000 0.55%
2017 124.916.000.000 55.29%
2018 76.092.000.000 -64.16%
2019 52.556.000.000 -44.78%
2020 35.709.000.000 -47.18%
2021 77.123.000.000 53.7%
2022 -36.331.000.000 312.28%
2023 31.170.000.000 216.56%
2023 13.260.000.000 -135.07%
2024 -12.176.000.000 208.9%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Eisai Co., Ltd. Operating Cashflow
Year Operating Cashflow Growth
1999 27.174.000.000
2000 84.996.000.000 68.03%
2001 56.864.000.000 -49.47%
2002 56.864.000.000 0%
2003 72.718.000.000 21.8%
2004 49.200.000.000 -47.8%
2005 87.053.000.000 43.48%
2006 81.188.000.000 -7.22%
2007 73.242.000.000 -10.85%
2008 104.988.000.000 30.24%
2009 107.947.000.000 2.74%
2010 123.157.000.000 12.35%
2011 90.624.000.000 -35.9%
2012 73.181.000.000 -23.84%
2013 85.687.000.000 14.59%
2014 76.022.000.000 -12.71%
2015 95.617.000.000 20.49%
2016 75.851.000.000 -26.06%
2017 149.649.000.000 49.31%
2018 103.714.000.000 -44.29%
2019 102.782.000.000 -0.91%
2020 73.853.000.000 -39.17%
2021 117.590.000.000 37.19%
2022 -1.772.000.000 6736%
2023 55.993.000.000 103.16%
2023 16.620.000.000 -236.9%
2024 -8.581.000.000 293.68%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Eisai Co., Ltd. Capital Expenditure
Year Capital Expenditure Growth
1999 16.302.000.000
2000 13.917.000.000 -17.14%
2001 22.800.000.000 38.96%
2002 22.800.000.000 0%
2003 25.127.000.000 9.26%
2004 39.205.000.000 35.91%
2005 43.837.000.000 10.57%
2006 28.558.000.000 -53.5%
2007 53.735.000.000 46.85%
2008 45.751.000.000 -17.45%
2009 31.259.000.000 -46.36%
2010 23.060.000.000 -35.56%
2011 19.487.000.000 -18.34%
2012 19.827.000.000 1.71%
2013 22.103.000.000 10.3%
2014 18.425.000.000 -19.96%
2015 40.072.000.000 54.02%
2016 20.001.000.000 -100.35%
2017 24.733.000.000 19.13%
2018 27.622.000.000 10.46%
2019 50.226.000.000 45%
2020 38.144.000.000 -31.67%
2021 40.467.000.000 5.74%
2022 34.559.000.000 -17.1%
2023 24.823.000.000 -39.22%
2023 3.360.000.000 -638.78%
2024 3.595.000.000 6.54%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Eisai Co., Ltd. Equity
Year Equity Growth
1999 338.898.000.000
2000 355.037.000.000 4.55%
2001 362.061.000.000 1.94%
2002 397.579.000.000 8.93%
2003 419.461.000.000 5.22%
2004 459.607.000.000 8.73%
2005 519.215.000.000 11.48%
2006 562.698.000.000 7.73%
2007 453.791.000.000 -24%
2008 433.045.000.000 -4.79%
2009 421.740.000.000 -2.68%
2010 410.370.000.000 -2.77%
2011 423.427.000.000 3.08%
2012 474.301.000.000 10.73%
2013 510.940.000.000 7.17%
2014 602.062.000.000 15.13%
2015 576.829.000.000 -4.37%
2016 602.591.000.000 4.28%
2017 614.098.000.000 1.87%
2018 651.982.000.000 5.81%
2019 702.630.000.000 7.21%
2020 727.942.000.000 3.48%
2021 771.533.000.000 5.65%
2022 822.571.000.000 6.2%
2023 898.975.000.000 8.5%
2023 884.845.000.000 -1.6%
2024 919.696.000.000 3.79%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Eisai Co., Ltd. Assets
Year Assets Growth
1999 485.673.000.000
2000 549.444.000.000 11.61%
2001 557.609.000.000 1.46%
2002 591.721.000.000 5.76%
2003 615.776.000.000 3.91%
2004 662.711.000.000 7.08%
2005 747.231.000.000 11.31%
2006 792.114.000.000 5.67%
2007 1.123.939.000.000 29.52%
2008 1.148.163.000.000 2.11%
2009 1.101.910.000.000 -4.2%
2010 1.046.291.000.000 -5.32%
2011 1.004.660.000.000 -4.14%
2012 990.249.000.000 -1.46%
2013 945.500.000.000 -4.73%
2014 1.053.818.000.000 10.28%
2015 973.987.000.000 -8.2%
2016 1.030.764.000.000 5.51%
2017 1.049.031.000.000 1.74%
2018 1.071.520.000.000 2.1%
2019 1.062.140.000.000 -0.88%
2020 1.090.009.000.000 2.56%
2021 1.239.315.000.000 12.05%
2022 1.263.350.000.000 1.9%
2023 1.393.799.000.000 9.36%
2023 1.333.993.000.000 -4.48%
2024 1.420.247.000.000 6.07%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Eisai Co., Ltd. Liabilities
Year Liabilities Growth
1999 146.775.000.000
2000 194.407.000.000 24.5%
2001 195.548.000.000 0.58%
2002 194.142.000.000 -0.72%
2003 196.315.000.000 1.11%
2004 203.104.000.000 3.34%
2005 228.016.000.000 10.93%
2006 229.416.000.000 0.61%
2007 670.148.000.000 65.77%
2008 715.118.000.000 6.29%
2009 680.170.000.000 -5.14%
2010 635.921.000.000 -6.96%
2011 581.233.000.000 -9.41%
2012 515.946.000.000 -12.65%
2013 434.559.000.000 -18.73%
2014 451.756.000.000 3.81%
2015 397.158.000.000 -13.75%
2016 428.173.000.000 7.24%
2017 434.933.000.000 1.55%
2018 419.538.000.000 -3.67%
2019 359.510.000.000 -16.7%
2020 362.067.000.000 0.71%
2021 467.782.000.000 22.6%
2022 440.779.000.000 -6.13%
2023 494.825.000.000 10.92%
2023 449.148.000.000 -10.17%
2024 500.551.000.000 10.27%

Eisai Co., Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2562.78
Net Income per Share
114.02
Price to Earning Ratio
49x
Price To Sales Ratio
2.18x
POCF Ratio
46.01
PFCF Ratio
62.8
Price to Book Ratio
1.79
EV to Sales
2.01
EV Over EBITDA
19.41
EV to Operating CashFlow
42.42
EV to FreeCashFlow
58.02
Earnings Yield
0.02
FreeCashFlow Yield
0.02
Market Cap
1.596,50 Bil.
Enterprise Value
1.474,90 Bil.
Graham Number
2832.85
Graham NetNet
184.04

Income Statement Metrics

Net Income per Share
114.02
Income Quality
0.88
ROE
0.04
Return On Assets
0.02
Return On Capital Employed
0.03
Net Income per EBT
0.66
EBT Per Ebit
1.58
Ebit per Revenue
0.04
Effective Tax Rate
0.31

Margins

Sales, General, & Administrative to Revenue
0.39
Research & Developement to Revenue
0.23
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.79
Operating Profit Margin
0.04
Pretax Profit Margin
0.07
Net Profit Margin
0.04

Dividends

Dividend Yield
0.03
Dividend Yield %
2.86
Payout Ratio
1.41
Dividend Per Share
160

Operating Metrics

Operating Cashflow per Share
121.43
Free CashFlow per Share
88.78
Capex to Operating CashFlow
0.27
Capex to Revenue
0.01
Capex to Depreciation
0.24
Return on Invested Capital
0.02
Return on Tangible Assets
0.03
Days Sales Outstanding
102.14
Days Payables Outstanding
187.84
Days of Inventory on Hand
460.21
Receivables Turnover
3.57
Payables Turnover
1.94
Inventory Turnover
0.79
Capex per Share
32.65

Balance Sheet

Cash per Share
1.061,42
Book Value per Share
3.211,82
Tangible Book Value per Share
2044.4
Shareholders Equity per Share
3128.25
Interest Debt per Share
645.74
Debt to Equity
0.2
Debt to Assets
0.13
Net Debt to EBITDA
-1.6
Current Ratio
2.36
Tangible Asset Value
585,41 Bil.
Net Current Asset Value
232,67 Bil.
Invested Capital
921844000000
Working Capital
422,20 Bil.
Intangibles to Total Assets
0.24
Average Receivables
210,91 Bil.
Average Payables
75,02 Bil.
Average Inventory
182626000000
Debt to Market Cap
0.11

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Eisai Co., Ltd. Dividends
Year Dividends Growth
2000 22
2001 26 19.23%
2002 32 18.75%
2003 34 5.88%
2004 39 12.82%
2005 75 48%
2006 105 28.57%
2007 130 19.23%
2008 135 3.7%
2009 140 3.57%
2010 150 6.67%
2011 150 0%
2012 150 0%
2013 150 0%
2014 150 0%
2015 150 0%
2016 150 0%
2017 150 0%
2018 150 0%
2019 160 6.25%
2020 160 0%
2021 160 0%
2022 160 0%
2023 160 0%
2024 160 0%
2025 0 0%

Eisai Co., Ltd. Profile

About Eisai Co., Ltd.

Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.

CEO
Mr. Haruo Naito
Employee
11.067
Address
4-6-10, Koishikawa
Tokyo, 112-8088

Eisai Co., Ltd. Executives & BODs

Eisai Co., Ltd. Executives & BODs
# Name Age
1 Mr. Masatomi Akana
Senior Vice President, Chief Government Relations Officer & Chief IR Officer
70
2 Shin Kato
Vice President, General Counsel & Chief Compliance Officer
70
3 Dr. Lynn D. Kramer FAAN, M.D.
Vice President & Chief Clinical Officer
70
4 Mr. Gary Hendler
Senior Vice President & President of EMEA Region
70
5 Mr. Haruo Naito
Chief Executive Officer, Representative Corporate Officer & Director
70
6 Mitsuru Shomon
Vice President & Chief Financial Officer
70
7 Makoto Hoketsu
Vice President & Chief Information Officer
70
8 Ms. Sayoko Sasaki
Vice President of Corporate Communications & Sustainability
70
9 Ms. Yanhui Feng
Senior Vice President
70
10 Mr. Keisuke Naito
Representative Corporate Officer, EVice President, Chief Operating Officer & Chief Growth Officer
70

Eisai Co., Ltd. Competitors